Effect of denosumab treatment on bone mineral density and bone turnover markers in osteoporotic patients: real-life experience 2-year follow-up
ARCHIVES OF OSTEOPOROSIS, cilt.17, sa.1, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17 Sayı: 1
- Basım Tarihi: 2022
- Doi Numarası: 10.1007/s11657-022-01145-2
- Dergi Adı: ARCHIVES OF OSTEOPOROSIS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Anahtar Kelimeler: Denosumab, Bone mineral density, Real-life experience, POSTMENOPAUSAL WOMEN, FRACTURE, THERAPY, RISK, DISCONTINUATION
- Marmara Üniversitesi Adresli: Evet
Özet
Denosumab leads to improvements in BMD levels and is a well-tolerated agent according to results of randomized controlled studies but results in real-life setting are important to evaluate drug adherence and real-life efficiency. In this study, we present the results of 305 patients that were treated with denosumab in our clinic.